PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Health Policy, London School of Economics and Political Science, London, UK. Electronic address: o.j.wouters@lse.ac.uk.\', \'Department of International Development, London School of Economics and Political Science, London, UK.\', \'Department of Health Policy, London School of Economics and Political Science, London, UK.\', \'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.\', \'Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Department of Health Metrics Sciences, University of Washington, Seattle, WA, USA.\', \'Health Intervention and Technology Assessment Program, Ministry of Public Health, Thailand; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.\', \'Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0140-6736(21)00306-810.1016/S0140-6736(21)00306-8
?:doi
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 33587887
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all